No one can fault President Trump for wanting Americans to have access to a coronavirus vaccine in the future, but Germany isn't pleased with the way he's reportedly trying to do it.
Per Reuters, Germany's health ministry confirmed a report from German Newspaper Welt am Sonntag that said Trump has offered funds to lure biopharmaceutical company CureVac, which is working on developing a vaccine for the new virus, from Germany to the United States. Welt am Sonntag quoted an anonymous German official who said Trump would do anything to get a vaccine, "but only for the United States."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The exclusive sale of a possible vaccine to the USA must be prevented by all means," tweeted Karl Lauterbach, a professor of health economics epidemiology and German lawmaker, in response to the report. "Capitalism has limits."
There was no immediate comment from the U.S. embassy in Berlin, and CureVac declined to comment, but the company's CEO Daniel Menichella met with Trump, Vice Presidnet Mike Pence, and other members of the White House Coronavirus Task Force earlier this month.
CureVac is narrowing its field of vaccine candidates, and hopes to begin testing in June or July. Read more at Reuters.
-
Massacre in the favela: Rio’s police take on the gangsIn the Spotlight The ‘defence operation’ killed 132 suspected gang members, but could spark ‘more hatred and revenge’
-
The John Lewis ad: touching, or just weird?Talking Point This year’s festive offering is full of 1990s nostalgia – but are hedonistic raves really the spirit of Christmas?
-
Codeword: November 15, 2025The daily codeword puzzle from The Week
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Argentinian beef is at the center of American farmers’ woesThe Explainer ‘It feels like a slap in the face to rural America,’ said one farmer
-
Will latest Russian sanctions finally break Putin’s resolve?Today's Big Question New restrictions have been described as a ‘punch to the gut of Moscow’s war economy’
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
China’s rare earth controlsThe Explainer Beijing has shocked Washington with export restrictions on minerals used in most electronics
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
The struggles of Aston Martin: burning cash not rubberIn the Spotlight The car manufacturer, famous for its association with the James Bond franchise, is ‘running out of road’
-
Why are beef prices rising? And how is politics involved?Today's Big Question Drought, tariffs and consumer demand all play a role
